Latest Clinical trial Stories
Study to Enroll 20 More Subjects PRINCETON, N.J., March 3, 2015 /PRNewswire/ -- Soligenix, Inc.
NEW YORK, March 3, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: IMNP) announced today that Dr.
Initial Phase 1 Safety Study Successfully Completed, Building on Promising Body of Preclinical Data CUPERTINO, Calif., March 2, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX)
NEW YORK, March 2, 2015 /PRNewswire/ -- Delcath Systems, Inc.
- Study reproduced earlier findings that a single, 2-hour intravenous administration of vepoloxamer resulted in robust improvements in key parameters of heart function that persisted for up to 2 weeks
TORONTO, March 2, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that its wholly owned subsidiary, Transition Therapeutics
A New Drug Approved for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer WOODCLIFF LAKE, N.J.,
-Strengthened balance sheet enables focus on both Kanuma(TM) (sebelipase alfa) and multiple pipeline programs- LEXINGTON, Mass., Feb.
Live Webcast from Boston on March 4th SAN DIEGO, Feb. 26, 2015 /PRNewswire/ -- MEI Pharma, Inc.
BOSTON, Feb. 26, 2015 /PRNewswire/ -- Columbia Laboratories, Inc.
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.